Catalys Pacific
Latest statistics and disclosures from Catalys Pacific's latest quarterly 13F-HR filing:
- Top 5 stock holdings are MLYS, PHAT, and represent 100.00% of Catalys Pacific's stock portfolio.
- Added to shares of these 1 stock: PHAT.
- Reduced shares in these 1 stock: MLYS (-$36M).
- Catalys Pacific was a net seller of stock by $-32M.
- Catalys Pacific has $311M in assets under management (AUM), dropping by -11.62%.
- Central Index Key (CIK): 0002011385
Tip: Access up to 7 years of quarterly data
Positions held by Catalys Pacific consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Catalys Pacific
Catalys Pacific holds 2 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Mineralys Therapeutics (MLYS) | 92.4 | $287M | -11% | 7.9M | 36.29 |
|
| Phathom Pharmaceuticals (PHAT) | 7.6 | $24M | +22% | 1.4M | 16.59 |
|
Past Filings by Catalys Pacific
SEC 13F filings are viewable for Catalys Pacific going back to 2024
- Catalys Pacific 2025 Q4 filed Feb. 10, 2026
- Catalys Pacific 2025 Q3 filed Nov. 14, 2025
- Catalys Pacific 2025 Q2 filed Aug. 13, 2025
- Catalys Pacific 2025 Q1 restated filed Aug. 13, 2025
- Catalys Pacific 2025 Q1 filed May 14, 2025
- Catalys Pacific 2024 Q4 filed Feb. 14, 2025
- Catalys Pacific 2024 Q3 filed Nov. 12, 2024
- Catalys Pacific 2024 Q2 filed Aug. 13, 2024